In Vitro Studies of Lymphocytes from Patients with Plasma Cell Myeloma. I. Stimulation by Mitogens and Cytotoxic Activities

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1973 Nov 1

PMID 4764348

Citations 14

Authors

H Mellstedt

G Holm

Affiliations

Soon will be listed here.

Citing Articles

Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). I. May induction of ab1-reactive T cells and anti-anti-idiotypic antibodies (ab3) lead to tumor regression after mAb therapy?.

Fagerberg J, Frodin J, Wigzell H, Mellstedt H Cancer Immunol Immunother. 1993; 37(4):264-70.

PMID: 8348565 PMC: 11038291. DOI: 10.1007/BF01518521.

Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.

Greenspan J, Gadol N, Olson J, Talal N Clin Exp Immunol. 1981; 44(3):603-10.

PMID: 7326870 PMC: 1537328.

Enzyme-induced modification of the surface properties of lymphoid cells in malignant disease. I. Effect of trypsin on rosette formation by lymphocytes in myelomatosis.

Fajumi J Br J Cancer. 1980; 41(2):183-8.

PMID: 6966155 PMC: 2010201. DOI: 10.1038/bjc.1980.28.

Activation of peripheral T cells of sarcoidosis patients and healthy controls.

Hedfors E Clin Exp Immunol. 1974; 18(3):379-90.

PMID: 4549733 PMC: 1537993.

In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers.

Mellstedt H, Jondal M, Holm G Clin Exp Immunol. 1973; 15(3):321-30.

PMID: 4543556 PMC: 1553908.

References

BORJESON J, Reisfeld R, CHESSIN L, Welsh P, Douglas S . Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med. 1966; 124(5):859-72. PMC: 2138267. DOI: 10.1084/jem.124.5.859. View

Holm G, Perlmann P . Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology. 1967; 12(5):525-36. PMC: 1409138. View

Holm G, Perlmann P, Johansson B . Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia. Clin Exp Immunol. 1967; 2(3):351-60. PMC: 1578852. View

Hobbs J . Paraproteins, benign or malignant?. Br Med J. 1967; 3(5567):699-704. PMC: 1843062. DOI: 10.1136/bmj.3.5567.699. View

Mogensen C . The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968; 21(1):77-82. DOI: 10.3109/00365516809076979. View

Lundgren G, Zukoski C, Moller G . Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol. 1968; 3(8):817-36. PMC: 1578963. View

Holm G, Perlmann P . Cytotoxicity of lymphocytes and its suppression. Antibiot Chemother. 1969; 15:295-309. DOI: 10.1159/000386787. View

Alexanian R, Haut A, Khan A, Lane M, MCKELVEY E, MIGLIORE P . Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA. 1969; 208(9):1680-5. DOI: 10.1001/jama.208.9.1680. View

Alexanian R, MIGLIORE P . Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy. J Lab Clin Med. 1970; 75(2):225-33. View

10.

Perlmann P, Holm G . Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969; 11:117-93. DOI: 10.1016/s0065-2776(08)60479-4. View

11.

Hobbs J . Immunocytoma o' mice an' men. Br Med J. 1971; 2(5753):67-72. PMC: 1795561. DOI: 10.1136/bmj.2.5753.67. View

12.

Janossy G, Greaves M . Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol. 1971; 9(4):483-98. PMC: 1713004. View

13.

Froland S, Natvig J, BERDAL P . Surface-bound immunoglobulin as a marker of B lymphocytes in man. Nat New Biol. 1971; 234(51):251-2. DOI: 10.1038/newbio234251a0. View

14.

Van Boxel J, Stobo J, Paul W, Green I . Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes. Science. 1972; 175(4018):194-6. DOI: 10.1126/science.175.4018.194. View

15.

Miller J, Mitchell G . Thymus and antigen-reactive cells. Transplant Rev. 1969; 1:3-42. DOI: 10.1111/j.1600-065x.1969.tb00135.x. View

16.

Smith R . Possibilities and problems of immunologic intervention in cancer. N Engl J Med. 1972; 287(9):439-50. DOI: 10.1056/NEJM197208312870905. View

17.

Mellstedt H, Jondal M, Holm G . In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers. Clin Exp Immunol. 1973; 15(3):321-30. PMC: 1553908. View

18.

Greaves M, Janossy G . Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant Rev. 1972; 11:87-130. DOI: 10.1111/j.1600-065x.1972.tb00047.x. View

19.

Perlmann P, Perlmann H, Wigzell H . Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972; 13:91-114. DOI: 10.1111/j.1600-065x.1972.tb00061.x. View

20.

Coulson A, CHALMERS D . SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD. Lancet. 1964; 1(7331):468-9. DOI: 10.1016/s0140-6736(64)90799-8. View